Floatz logo

Letrozole

Polycystic Ovary Syndrome

Fatima TariqSmall moleculePhase 4 / ApprovedActive
BBB
73/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
73/ 100
Competitive Position
73/ 100

Competitive context

60 Active assets in the Polycystic Ovary Syndrome cohort.

Asset / SponsorPhaseRating
Human Chorionic Gonadotropin
Eman Basuni Ebrahim Mowad
Phase 4BBB
Liraglutide
Peking University Third Hospital
Phase 4BBB
Semaglutide
Methodist Health System
Phase 4BBB
Follitropin Beta
Universitair Ziekenhuis Brussel
Phase 4BBB
Drospirenone
Ege University
Phase 4BBB

View all 49 →

Same molecule, other indications

Letrozole is also rated in:

infertility disorderActive
BBB
Indicative · Phase 4
79 / 100
View asset →
anovulationActive
BBB
Indicative · Phase 4
78 / 100
View asset →
invasive breast carcinomaActive
BBB
Indicative · Phase 4
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →